Nigerian Scientist Produces Experimental Drug For Ebola

Nigeria has received an experimental drug from an unnamed Nigerian scientist to treat Ebola virus, the minister of Health, Onyebuchi Chukwu, announced in Abuja on Thursday.

Chukwu, who gave the cheery news at a news conference, said the name of the drug is “Nanosilver”.

“The only experimental drug we have now is Nanosilver, provided by a Nigerian scientist; details of the drug will be disclosed later to the media,” the minister said.

He, however, said the country has confirmed 11 cases of the Ebola virus, out of which three are dead, Patrick Sawyer, a Nigeria nurse and ECOWAS protocol officer.

Onyebuchi stressed that apart from Lagos, there was no Ebola case in any states of the federation, thereby debunking a report that another nurse had died from the disease in Enugu State.

According to him,  the nurse under surveillance in Lagos who travelled to Enugu was back to Lagos with members of her family for close monitoring.

“Nobody in Enugu has Ebola disease, all cases are still confined within Lagos’’, said Chukwu.



    Chukwu said that the suspected cases that were reported in Abia, Anambra, and Abuja were investigated and proved negative.

    Meanwhile, the chief executive officer of Aliko Dangote Foundation, Aliko Dangote has announced the donation of N150 million for the Ebola Emergency Operation Centre in Lagos.

    The minister of Information, Labaran Maku, thanked the donor and urged all Nigerians to emulate the gesture.

    He also thanked international partners for their donations, saying that the federal government was doing everything possible to ensure that the disease did not escalate.

    Join the ICIR WhatsApp channel for in-depth reports on the economy, politics and governance, and investigative reports.

    Support the ICIR

    We invite you to support us to continue the work we do.

    Your support will strengthen journalism in Nigeria and help sustain our democracy.

    If you or someone you know has a lead, tip or personal experience about this report, our WhatsApp line is open and confidential for a conversation


    Please enter your comment!
    Please enter your name here

    Support the ICIR

    We need your support to produce excellent journalism at all times.

    - Advertisement


    - Advertisement